CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor

Pier P. Scaglioni, T. M. Yung, S. C. Choi, C. Baldini, G. Konstantinidou, P. P. Pandolfi

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The PML tumor suppressor controls growth suppression, induction of apoptosis, and cellular senescence. PML loss occurs frequently in hematopoietic and solid tumors. PML loss often correlates with tumor progression. Casein kinase 2 (CK2) is a stress-activated serine/ threonine protein kinase that is oncogenic and frequently overexpressed in human tumor of multiple histological origins. In addition, CK2 overexpression due to gene amplification has been reported to be an adverse prognostic factor in non-small cell lung cancer. At the 5th International Conference on Protein Kinase CK2 in Padova, Italy, we reviewed our recent findings that PML undergoes ubiquitin/ proteasome-mediated degradation in immortalized and tumor derived cell lines. PML degradation depends on direct CK2 phosphorylation of PML Ser517. PML mutants that are resistant to CK2 phosphorylation display increased tumor suppressive functions in assays measuring apoptosis, replicative senescence, and in xenograft models. More significantly, CK2 pharmacological inhibition enhances PML tumor suppressive property. These data identify a key post-translational mechanism that controls PML protein levels in cancer cells and suggest that CK2 inhibitors may be beneficial anti-cancer drugs.

Original languageEnglish (US)
Pages (from-to)149-154
Number of pages6
JournalMolecular and Cellular Biochemistry
Volume316
Issue number1-2
DOIs
StatePublished - 2008

Fingerprint

Casein Kinase II
Phosphorylation
Ubiquitin
Tumors
Degradation
Neoplasms
Cells
Cell Aging
Apoptosis
Protein-Serine-Threonine Kinases
Proteasome Endopeptidase Complex
Gene Amplification
Heterografts
Protein Kinases
Tumor Cell Line
Assays
Non-Small Cell Lung Carcinoma
Italy
Display devices
Pharmacology

Keywords

  • CK2
  • Lung cancer pathogenesis
  • PML
  • Protein polyubiquitination

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Molecular Biology
  • Genetics
  • Cell Biology

Cite this

Scaglioni, P. P., Yung, T. M., Choi, S. C., Baldini, C., Konstantinidou, G., & Pandolfi, P. P. (2008). CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor. Molecular and Cellular Biochemistry, 316(1-2), 149-154. https://doi.org/10.1007/s11010-008-9812-7

CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor. / Scaglioni, Pier P.; Yung, T. M.; Choi, S. C.; Baldini, C.; Konstantinidou, G.; Pandolfi, P. P.

In: Molecular and Cellular Biochemistry, Vol. 316, No. 1-2, 2008, p. 149-154.

Research output: Contribution to journalArticle

Scaglioni, PP, Yung, TM, Choi, SC, Baldini, C, Konstantinidou, G & Pandolfi, PP 2008, 'CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor', Molecular and Cellular Biochemistry, vol. 316, no. 1-2, pp. 149-154. https://doi.org/10.1007/s11010-008-9812-7
Scaglioni, Pier P. ; Yung, T. M. ; Choi, S. C. ; Baldini, C. ; Konstantinidou, G. ; Pandolfi, P. P. / CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor. In: Molecular and Cellular Biochemistry. 2008 ; Vol. 316, No. 1-2. pp. 149-154.
@article{1dd288752313474d97e769e00c042f0b,
title = "CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor",
abstract = "The PML tumor suppressor controls growth suppression, induction of apoptosis, and cellular senescence. PML loss occurs frequently in hematopoietic and solid tumors. PML loss often correlates with tumor progression. Casein kinase 2 (CK2) is a stress-activated serine/ threonine protein kinase that is oncogenic and frequently overexpressed in human tumor of multiple histological origins. In addition, CK2 overexpression due to gene amplification has been reported to be an adverse prognostic factor in non-small cell lung cancer. At the 5th International Conference on Protein Kinase CK2 in Padova, Italy, we reviewed our recent findings that PML undergoes ubiquitin/ proteasome-mediated degradation in immortalized and tumor derived cell lines. PML degradation depends on direct CK2 phosphorylation of PML Ser517. PML mutants that are resistant to CK2 phosphorylation display increased tumor suppressive functions in assays measuring apoptosis, replicative senescence, and in xenograft models. More significantly, CK2 pharmacological inhibition enhances PML tumor suppressive property. These data identify a key post-translational mechanism that controls PML protein levels in cancer cells and suggest that CK2 inhibitors may be beneficial anti-cancer drugs.",
keywords = "CK2, Lung cancer pathogenesis, PML, Protein polyubiquitination",
author = "Scaglioni, {Pier P.} and Yung, {T. M.} and Choi, {S. C.} and C. Baldini and G. Konstantinidou and Pandolfi, {P. P.}",
year = "2008",
doi = "10.1007/s11010-008-9812-7",
language = "English (US)",
volume = "316",
pages = "149--154",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - CK2 mediates phosphorylation and ubiquitin-mediated degradation of the PML tumor suppressor

AU - Scaglioni, Pier P.

AU - Yung, T. M.

AU - Choi, S. C.

AU - Baldini, C.

AU - Konstantinidou, G.

AU - Pandolfi, P. P.

PY - 2008

Y1 - 2008

N2 - The PML tumor suppressor controls growth suppression, induction of apoptosis, and cellular senescence. PML loss occurs frequently in hematopoietic and solid tumors. PML loss often correlates with tumor progression. Casein kinase 2 (CK2) is a stress-activated serine/ threonine protein kinase that is oncogenic and frequently overexpressed in human tumor of multiple histological origins. In addition, CK2 overexpression due to gene amplification has been reported to be an adverse prognostic factor in non-small cell lung cancer. At the 5th International Conference on Protein Kinase CK2 in Padova, Italy, we reviewed our recent findings that PML undergoes ubiquitin/ proteasome-mediated degradation in immortalized and tumor derived cell lines. PML degradation depends on direct CK2 phosphorylation of PML Ser517. PML mutants that are resistant to CK2 phosphorylation display increased tumor suppressive functions in assays measuring apoptosis, replicative senescence, and in xenograft models. More significantly, CK2 pharmacological inhibition enhances PML tumor suppressive property. These data identify a key post-translational mechanism that controls PML protein levels in cancer cells and suggest that CK2 inhibitors may be beneficial anti-cancer drugs.

AB - The PML tumor suppressor controls growth suppression, induction of apoptosis, and cellular senescence. PML loss occurs frequently in hematopoietic and solid tumors. PML loss often correlates with tumor progression. Casein kinase 2 (CK2) is a stress-activated serine/ threonine protein kinase that is oncogenic and frequently overexpressed in human tumor of multiple histological origins. In addition, CK2 overexpression due to gene amplification has been reported to be an adverse prognostic factor in non-small cell lung cancer. At the 5th International Conference on Protein Kinase CK2 in Padova, Italy, we reviewed our recent findings that PML undergoes ubiquitin/ proteasome-mediated degradation in immortalized and tumor derived cell lines. PML degradation depends on direct CK2 phosphorylation of PML Ser517. PML mutants that are resistant to CK2 phosphorylation display increased tumor suppressive functions in assays measuring apoptosis, replicative senescence, and in xenograft models. More significantly, CK2 pharmacological inhibition enhances PML tumor suppressive property. These data identify a key post-translational mechanism that controls PML protein levels in cancer cells and suggest that CK2 inhibitors may be beneficial anti-cancer drugs.

KW - CK2

KW - Lung cancer pathogenesis

KW - PML

KW - Protein polyubiquitination

UR - http://www.scopus.com/inward/record.url?scp=50649105487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50649105487&partnerID=8YFLogxK

U2 - 10.1007/s11010-008-9812-7

DO - 10.1007/s11010-008-9812-7

M3 - Article

C2 - 18566754

AN - SCOPUS:50649105487

VL - 316

SP - 149

EP - 154

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -